Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and VLDL Cholesterol. A Consensus Statement from EAS and EFLM. (Q53818901)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and VLDL Cholesterol. A Consensus Statement from EAS and EFLM. |
scientific article |
Statements
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and VLDL Cholesterol. A Consensus Statement from EAS and EFLM. (English)
1 reference
Alberico Catapano
1 reference
Arnold von Eckardstein
1 reference
Jan Borén
1 reference
Olov Wiklund
1 reference
Nader Rifai
1 reference
Gerald F Watts
1 reference
Alan T Remaley
1 reference
Michel R Langlois
1 reference
M John Chapman
1 reference
Christa Cobbaert
1 reference
Samia Mora
1 reference
Emilio Ros
1 reference
Hannsjörg Baum
1 reference
Eric Bruckert
1 reference
Olivier S Descamps
1 reference
Pia R Kamstrup
1 reference
Genovefa Kolovou
1 reference
Florian Kronenberg
1 reference
Anne Langsted
1 reference
Kari Pulkki
1 reference
Grazyna Sypniewska
1 reference
B Rge G Nordestgaard
1 reference
European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative
1 reference
14 May 2018
1 reference
Identifiers
1 reference